Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Orgogozo

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Dementia and Geriatric Cognitive Disorders|February 24, 2001
New millennium: new expectations for Alzheimer's disease?J M Orgogozo
La Revue Du Praticien|December 15, 1992
[Fibrinolytic agents in cerebral ischemic accidents. A hope more reserved than in myocardial infarction]J M Orgogozo
Advances in Neurology|January 1, 1979
Comments on the treatment of cerebrovascular disordersJ M Orgogozo
L'Encephale|January 1, 1976
[Gerstmann's syndrome (critical review of the literature)]J M Orgogozo
Pharmacopsychiatry|May 25, 1999
Piracetam in the treatment of acute strokeJ M Orgogozo
Revue Neurologique|August 6, 2008
[Anti-amyloid immunotherapy in Alzheimer's disease]J-M Orgogozo
Cerebrovascular Diseases (Basel, Switzerland)|May 7, 1998
Advantages and disadvantages of neurological scalesJ M Orgogozo
Postgraduate Medical Journal|May 1, 1987
Critical review of clinical trials in senile dementia--IIJ M Orgogozo, R Spiegel
Alzheimer Disease and Associated Disorders|December 28, 1999
Vascular dementia: European perspectivesJ M Orgogozo, E Abadie
Neurologia (Barcelona, Spain)|May 1, 1995
Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapyF Boller, J M Orgogozo
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Dementia and Geriatric Cognitive Disorders|February 24, 2001
New millennium: new expectations for Alzheimer's disease?J M Orgogozo
La Revue Du Praticien|December 15, 1992
[Fibrinolytic agents in cerebral ischemic accidents. A hope more reserved than in myocardial infarction]J M Orgogozo
Advances in Neurology|January 1, 1979
Comments on the treatment of cerebrovascular disordersJ M Orgogozo
L'Encephale|January 1, 1976
[Gerstmann's syndrome (critical review of the literature)]J M Orgogozo
Pharmacopsychiatry|May 25, 1999
Piracetam in the treatment of acute strokeJ M Orgogozo
Revue Neurologique|August 6, 2008
[Anti-amyloid immunotherapy in Alzheimer's disease]J-M Orgogozo
Cerebrovascular Diseases (Basel, Switzerland)|May 7, 1998
Advantages and disadvantages of neurological scalesJ M Orgogozo
Postgraduate Medical Journal|May 1, 1987
Critical review of clinical trials in senile dementia--IIJ M Orgogozo, R Spiegel
Alzheimer Disease and Associated Disorders|December 28, 1999
Vascular dementia: European perspectivesJ M Orgogozo, E Abadie
Neurologia (Barcelona, Spain)|May 1, 1995
Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapyF Boller, J M Orgogozo
Pageof 14